Multimeric ELP Spider Complexes for Protein Purification

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for purifying recombinant proteins are inefficient and prone to proteolysis, limiting the production yield and stability of protein products.

Innovation Solution

Development of multimeric elastin-like peptide (ELP) constructs that form spider complexes through disulfide bonds, enabling easier purification and enhanced proteolytic resistance by using ELP tags and spacer sequences to facilitate inverse phase transition cycling.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If traditional purification methods are used for recombinant proteins, then the purification process can be performed with standard techniques, but the purification efficiency is low and the proteins are prone to proteolysis

Engineering Contradiction:
Improvepurification efficiencyVSAvoidproteolytic stability
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The invention creates a composite fusion protein structure combining the target protein with elastin-like peptide (ELP) tags. This composite construct provides dual functionality: the ELP tags enable temperature-responsive phase transition for efficient purification while the fusion structure protects the target protein from proteolytic degradation, simultaneously improving both purification efficiency and proteolytic stability

Inventive Principle:
Principle #40Composite materials

Solution Approach 2:

The invention utilizes the inverse temperature transition property of elastin-like peptides. Below the transition temperature (Tt), the ELP-tags are soluble and the fusion protein remains in solution. Above Tt, the ELP-tags undergo phase transition to become insoluble, enabling easy separation of the target protein through precipitation or centrifugation. This phase transition mechanism dramatically improves purification efficiency while the fusion structure maintains proteolytic stability

Inventive Principle:
Principle #36Phase transitions

2Productivity

If standard protein expression systems are used, then the expression process is straightforward, but the production yield is limited and proteolytic degradation occurs

Engineering Contradiction:
Improveproduction yieldVSAvoidproteolytic degradation
Core Design Contradiction:
ProductivityVSObject-generated harmful factors

Solution Approach 1:

The elastin-like peptide tags serve as an intermediary structure in the fusion protein. This intermediary element does not interfere with the function of the target protein but provides protective functionality by forming a physical barrier against proteases and enabling temperature-controlled recovery, thereby increasing production yield while reducing proteolytic degradation

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The temperature-induced phase transition of ELP tags allows for efficient recovery of the target protein at high yields. By expressing the fusion protein at temperatures below Tt and then inducing phase transition above Tt, the target protein can be recovered in high quantity through simple centrifugation or filtration, significantly improving production yield while the fusion structure protects against proteolytic degradation throughout the process

Inventive Principle:
Principle #36Phase transitions

3Device complexity

If simple ELP fusion constructs are used, then the construct design is straightforward, but the purification process is complex and proteolytic resistance is insufficient

Engineering Contradiction:
Improveconstruct design simplicityVSAvoidpurification efficiency
Core Design Contradiction:
Device complexityVSProductivity

Solution Approach 1:

The invention employs the inherent phase transition property of elastin-like peptides to create a simple yet highly effective purification system. The ELP-tags in the fusion construct undergo temperature-induced phase transition, allowing purification to be achieved through simple temperature cycling and centrifugation rather than complex chromatographic methods, thereby improving purification efficiency while maintaining construct design simplicity

Inventive Principle:
Principle #36Phase transitions

Solution Approach 2:

The fusion protein construct combines the target protein with ELP tags to create a composite structure that provides both purification functionality and proteolytic protection. This composite design achieves efficient purification through the temperature-responsive properties of ELP while simultaneously enhancing proteolytic resistance, all within a relatively simple construct design that can be implemented using standard molecular biology techniques

Inventive Principle:
Principle #40Composite materials

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The ELP spider complexes improve protein purification efficiency, increase production yields, and reduce proteolytic degradation, resulting in higher purity and stability of target proteins.

Implementation Method 1

ELPs undergo a reversible inverse temperature transition: they are structurally disordered and highly soluble in water below a transition temperature (Tt), but exhibit a sharp (2-3° C. range) disorder-to-order phase transition when the temperature is raised above Tt, leading to desolvation and aggregation of the polypeptides.

Methodology Applied
Scientific EffectInverse temperature transition: Phase Change

Implementation Method 2

The fusion protein contains at least two residues capable of forming a disulfide bond

Methodology Applied
Scientific EffectDisulfide bond formation: Chemical Bonding

Data Source

PatentUS7709227B2Multimeric ELP fusion constructs
Publication Date: 2010.05.04 PHASEBIO PHARMACEUTICALS INC
  • US7709227B2 patent drawing
  • US7709227B2 patent drawing
  • US7709227B2 patent drawing

AI summary

ELP fusion proteins, multimeric ELP spider complexes formed of ELP fusion proteins, and methods of using the same. The construct may be in the form of an ELP spider structure complex including multi-leg moieties comprising ELP fusion proteins capable of forming covalent disulfide bonds. The multimeric fusion constructs may be employed in peptide production and purification and/or to enhance protelytic resistance of a protein or peptide moiety in a fusion construct, by provision of the fusion protein in an ELP spider complex.